Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9722)
All Articles published online
|
Publishing Process of This Article
|
Oct 7, 2014 (publication date) through Nov 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Murata S, Mine T, Sugihara F, Yasui D, Yamaguchi H, Ueda T, Onozawa S, Kumita SI. Interventional treatment for unresectable hepatocellular carcinoma. World J Gastroenterol 2014; 20(37): 13453-13465 [PMID: 25309076 DOI: 10.3748/wjg.v20.i37.13453] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i37/13453.htm |
| Number | Citing Articles |
| 1 |
Yaoping Shi, Bo Zhai. A Recent Advance in Image-Guided Locoregional Therapy for Hepatocellular Carcinoma. Gastrointestinal Tumors 2016; 3(2): 90 doi: 10.1159/000445888
|
| 2 |
Houqiao Bai, Peng Gao, Hao Gao, Guangxi Sun, Chonghai Dong, Jian Han, Guosheng Jiang. Improvement of Survival Rate for Patients with Hepatocellular Carcinoma Using Transarterial Chemoembolization in Combination with Three-Dimensional Conformal Radiation Therapy: A Meta-Analysis. Medical Science Monitor 2016; 22: 1773 doi: 10.12659/MSM.895548
|
| 3 |
B. T. Welch, J. J. Schmitz, T. D. Atwell, A. M. McGauvran, A. N. Kurup, M. R. Callstrom, G. D. Schmit. Evaluation of infectious complications following percutaneous liver ablation in patients with bilioenteric anastomoses. Abdominal Radiology 2017; 42(5): 1579 doi: 10.1007/s00261-017-1051-5
|
| 4 |
Sirish A. Kishore, Raazi Bajwa, David C. Madoff. Embolotherapeutic Strategies for Hepatocellular Carcinoma: 2020 Update. Cancers 2020; 12(4): 791 doi: 10.3390/cancers12040791
|
| 5 |
Chang-Hsien Liu, Cheng-Ming Peng, Jen-I. Hwang, Po-Chin Liang, Pei-Jer Chen, Nadine Abi-Jaoudeh, Lung-Hui Giiang, Yu-Shen Tyan. Phase I Dose-Escalation Study of Tirapazamine Chemoembolization for Unresectable Early- and Intermediate-Stage Hepatocellular Carcinoma. Journal of Vascular and Interventional Radiology 2022; 33(8): 926 doi: 10.1016/j.jvir.2022.04.031
|
| 6 |
Roberto Iezzi, Maurizio Pompili, Emanuele Rinninella, Eleonora Annicchiarico, Matteo Garcovich, Lucia Cerrito, Francesca Ponziani, AnnaMaria De Gaetano, Massimo Siciliano, Michele Basso, Maria Assunta Zocco, GianLodovico Rapaccini, Alessandro Posa, Francesca Carchesio, Marco Biolato, Felice Giuliante, Antonio Gasbarrini, Riccardo Manfredi. TACE with degradable starch microspheres (DSM-TACE) as second-line treatment in HCC patients dismissing or ineligible for sorafenib. European Radiology 2019; 29(3): 1285 doi: 10.1007/s00330-018-5692-8
|
| 7 |
Dong Lv, Yuan Wang, Ying Zhang, Peilin Cui, Youqing Xu. Downregulated long non-coding RNA DREH promotes cell proliferation in hepatitis B virus-associated hepatocellular carcinoma. Oncology Letters 2017; 14(2): 2025 doi: 10.3892/ol.2017.6436
|
| 8 |
Yuko Takami, Susumu Eguchi, Masaki Tateishi, Tomoki Ryu, Kazuhiro Mikagi, Yoshiyuki Wada, Hideki Saitsu. A randomised controlled trial of meloxicam, a Cox-2 inhibitor, to prevent hepatocellular carcinoma recurrence after initial curative treatment. Hepatology International 2016; 10(5): 799 doi: 10.1007/s12072-016-9704-y
|
| 9 |
Yang-Yang Fu, Wen-Mao Li, Hong-Qiao Cai, Yan Jiao. Landscape of transarterial chemoembolization represented interventional therapy for hepatocellular carcinoma. World Journal of Gastrointestinal Surgery 2024; 16(12): 3903-3906 doi: 10.4240/wjgs.v16.i12.3903
|
| 10 |
Yi-Lan Lin. Proton beam therapy in apneic oxygenation treatment of an unresectable hepatocellular carcinoma: A case report and review of literature. World Journal of Hepatology 2018; 10(10): 772-779 doi: 10.4254/wjh.v10.i10.772
|
| 11 |
Pietro Di Fazio, Petra Waldegger, Samir Jabari, Susanne Lingelbach, Roberta Montalbano, Matthias Ocker, Emily P. Slater, Detlef K. Bartsch, Romana Illig, Daniel Neureiter, Thaddeus T. Wissniowski. Autophagy-related cell death by pan-histone deacetylase inhibition in liver cancer. Oncotarget 2016; 7(20): 28998 doi: 10.18632/oncotarget.8585
|
| 12 |
Daisuke Yasui, Satoru Murata, Tatsuo Ueda, Fumie Sugihara, Shiro Onozawa, Chiaki Kawamoto, Shinichiro Kumita. Novel treatment strategy for advanced hepatocellular carcinoma: combination of conventional transcatheter arterial chemoembolization and modified method with portal vein occlusion for cases with arterioportal shunt: a preliminary study. Acta Radiologica 2018; 59(3): 266 doi: 10.1177/0284185117717762
|
| 13 |
Roberto Iezzi, Alessandro Posa, Marco Santoro, Alessandro Tanzilli, Lucia Cerrito, Francesca Romana Ponziani, Maurizio Pompili, Antonio Grieco, Gian Ludovico Rapaccini, Antonio Gasbarrini, Riccardo Manfredi. Balloon-Occluded Radiofrequency Ablation as Bridge to TACE in the
Treatment of Advanced HCC with Arterioportal Shunt. Current Radiopharmaceuticals 2022; 15(3): 194 doi: 10.2174/1874471015666220223102426
|
| 14 |
Zi-Yi Zhu, Zhen Qian, Zhong-Qiang Qin, Bo Xie, Jian-Zhu Wei, Pei-Pei Yang, Mu Yuan. Effectiveness and safety of sequential transarterial chemoembolization and microwave ablation for subphrenic hepatocellular carcinoma: A comprehensive evaluation. World Journal of Gastrointestinal Oncology 2024; 16(7): 2941-2951 doi: 10.4251/wjgo.v16.i7.2941
|
| 15 |
Jungang Hu, Majid Maybody, Guang Cao, Xiao Wang, Hui Chen, Xu Zhu, Renjie Yang, Xiaodong Wang. Lipiodol retention pattern assessed by cone beam computed tomography during conventional transarterial chemoembolization of hepatocellular carcinoma: accuracy and correlation with response. Cancer Imaging 2016; 16(1) doi: 10.1186/s40644-016-0090-4
|
| 16 |
Asanda Koza, Ricky H. Bhogal, Nicos Fotiadis, Vasileios K. Mavroeidis. The Role of Ablative Techniques in the Management of Hepatocellular Carcinoma: Indications and Outcomes. Biomedicines 2023; 11(4): 1062 doi: 10.3390/biomedicines11041062
|
| 17 |
Ali Habib, Kush Desai, Ryan Hickey, Bartley Thornburg, Robert Lewandowski, Riad Salem. Locoregional Therapy of Hepatocellular Carcinoma. Clinics in Liver Disease 2015; 19(2): 401 doi: 10.1016/j.cld.2015.01.008
|
| 18 |
Jingxin Yan, Manjun Deng, Ting Li, Changhao Dong, Minglan Wang, Shunyu Kong, Yingxing Guo, Haining Fan. Efficacy and complications of transarterial chemoembolization alone or in combination with different protocols for hepatocellular carcinoma: A Bayesian network meta-analysis of randomized controlled trials. iLIVER 2023; 2(2): 130 doi: 10.1016/j.iliver.2023.03.002
|
| 19 |
Xiu-Li Gao, Hua Lin, Wei Zhao, Ya-Qin Hou, Yong-Li Bao, Zhen-Bo Song, Lu-Guo Sun, Shang-Yi Tian, Biao Liu, Yu-Xin Li. JA, a new type of polyunsaturated fatty acid isolated from Juglans mandshurica Maxim, limits the survival and induces apoptosis of heptocarcinoma cells. Apoptosis 2016; 21(3): 340 doi: 10.1007/s10495-015-1202-5
|
| 20 |
Brian T. Welch, J. J. Schmitz, A. N. Kurup, T. D. Atwell, M. R. Callstrom, G. Frey, R. Paz-Fumagalli, A. Allen, K. Watt, J. Heimbach, G. D. Schmit. Feasibility and outcomes of percutaneous thermal ablation of hepatocellular carcinoma in a transplanted allograft. Abdominal Radiology 2018; 43(6): 1478 doi: 10.1007/s00261-017-1323-0
|
| 21 |
Kung-Hao Liang, Chih-Lang Lin, Sung-Fang Chen, Chih-Wei Chiu, Pei-Ching Yang, Ming-Ling Chang, Chen-Chun Lin, Kai-Feng Sung, Cassandra Yeh, Chien-Fu Hung, Rong-Nan Chien, Chau-Ting Yeh.
GALNT14
Genotype Effectively Predicts The Therapeutic Response in Unresectable Hepatocellular Carcinoma Treated with Transcatheter Arterial Chemoembolization
. Pharmacogenomics 2016; 17(4): 353 doi: 10.2217/pgs.15.179
|
| 22 |
Gabor Varbiro. Enhancement of the Cytotoxic Effect of Anticancer Agent by Cytochrome c Functionalised Hybrid Nanoparticles in Hepatocellular Cancer Cells. Journal of Nanomedicine Research 2014; 1(2) doi: 10.15406/jnmr.2014.01.00010
|
| 23 |
Ni Zeng, Ye Wang, Yuan Wan, Hongyu Wang, Nan Li. The Antitumor Impact of Combining Hepatic Artery Ligation With Copper Chelators for Liver Cancer. Clinical Medicine Insights: Oncology 2023; 17 doi: 10.1177/11795549231204612
|
| 24 |
Fumie Sugihara, Satoru Murata, Tatsuo Ueda, Daisuke Yasui, Hidenori Yamaguchi, Izumi Miki, Chiaki Kawamoto, Eiji Uchida, Shin-ichiro Kumita. Haemodynamic changes in hepatocellular carcinoma and liver parenchyma under balloon occlusion of the hepatic artery. European Radiology 2017; 27(6): 2474 doi: 10.1007/s00330-016-4573-2
|
| 25 |
Dongyan Wu, Huaisong Wang, Xiaoshuang Hou, Huan Chen, Yu Ma, Yanglong Hou, Jin Hong, Ya Ding. Effects of gold core size on regulating the performance of doxorubicin-conjugated gold nanoparticles. Nano Research 2018; 11(6): 3396 doi: 10.1007/s12274-017-1963-y
|
| 26 |
Liming Lu, Jingchun Zeng, Zehuai Wen, Chunzhi Tang, Nenggui Xu. Transcatheter arterial chemoembolisation followed by three-dimensional conformal radiotherapy versus transcatheter arterial chemoembolisation alone for primary hepatocellular carcinoma in adults. Cochrane Database of Systematic Reviews 2019; 2019(2) doi: 10.1002/14651858.CD012244.pub2
|
| 27 |
Hanyao Sun, Wei Yang, Weizhong Zhou, Chungao Zhou, Sheng Liu, Haibin Shi, Wei Tian. Prognostic value of des‑γ‑carboxyprothrombin in patients with AFP‑negative HCC treated with TACE. Oncology Letters 2022; 25(2) doi: 10.3892/ol.2022.13655
|
| 28 |
Liming Lu, Jingchun Zeng, Zehuai Wen. Combination of three-dimensional conformal radiotherapy and transcatheter arterial chemoembolisation versus transcatheter arterial chemoembolisation for primary hepatocellular carcinoma. Cochrane Database of Systematic Reviews 2016; doi: 10.1002/14651858.CD012244
|
| 29 |
Long Gao, Jian Zhang, Tengchuang Ma, Nan Yao, Meng Gao, Xin Shan, Yicheng Ni, Haibo Shao, Ke Xu. Improved therapeutic outcomes of thermal ablation on rat orthotopic liver allograft sarcoma models by radioiodinated hypericin induced necrosis targeted radiotherapy. Oncotarget 2016; 7(32): 51450 doi: 10.18632/oncotarget.9848
|
| 30 |
Abdalla Aly, Melissa Lingohr-Smith, Jay Lin, Brian Seal. Locoregional therapy patterns and healthcare economic burden of patients with hepatocellular carcinoma in the USA. Hepatic Oncology 2021; 8(3) doi: 10.2217/hep-2021-0001
|
| 31 |
Jingxin Yan, Manjun Deng, Ting Li, Yaxuan Wang, Jiaxin Wu, LuShun Zhang, Haining Fan. Transarterial chemoembolisation plus I125 seeds implantation for people with unresectable hepatocellular carcinoma. Cochrane Database of Systematic Reviews 2022; 2022(12) doi: 10.1002/14651858.CD015389
|
| 32 |
Zhaoyuan Liu, Qing Peng, Yang Li, Yi Gao. Resveratrol enhances cisplatin-induced apoptosis in human hepatoma cells via glutamine metabolism inhibition. BMB Reports 2018; 51(9): 474 doi: 10.5483/BMBRep.2018.51.9.114
|
| 33 |
Chang Jin Yoon, Jin Wook Chung. Blumgart's Surgery of the Liver, Biliary Tract and Pancreas, 2-Volume Set. 2017; : 1398 doi: 10.1016/B978-0-323-34062-5.00096-0
|
| 34 |
Jianghai Zhao, Hui Zhang, Lunshou Wei, Shuping Xie, Zhimin Suo. Comparing the long-term efficacy of standard and combined minimally invasive procedures for unresectable HCC: a mixed treatment comparison. Oncotarget 2017; 8(9): 15101 doi: 10.18632/oncotarget.13145
|
| 35 |
Feng Xia, Qiao Zhang, Xiaoping Chen, Bixiang Zhang, Elijah Ndhlovu, Mingyu Zhang, Peng Zhu. Comparison of the prognosis of BCLC stage A ruptured hepatocellular carcinoma patients after undergoing transarterial chemoembolization (TACE) or hepatectomy: a propensity score-matched landmark analysis. Surgical Endoscopy 2022; 36(12): 8992 doi: 10.1007/s00464-022-09351-2
|